| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:45 | Infineon Aktie: Rallyemodus? - ABO Energy, Deutsche Börse, Evotec, Renk und Rheinmetall im Marktbericht Börse Frankfurt | 786 | 4investors | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| 07:00 | Roche, Novo Nordisk und NurExone: Der Prix Galien würdigt Innovation und Fachkompetenz in der Biopharmazie | Small- & Micro Cap Investment | |||
| Fr | Hagens Berman Sobol Shapiro LLP: MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman | 500 | PR Newswire | SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ -- MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities... ► Artikel lesen | |
| 03:02 | MedMira, Inc.: MedMira Reports FY2025 Fourth Quarter and Year End Financial Results | 327 | ACCESS Newswire | HALIFAX, NOVA SCOTIA / ACCESS Newswire / November 28, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the financial year ended July 31, 2025.Corporate updateIn... ► Artikel lesen | |
| 02:26 | Rapid Dose Therapeutics Corp.: Rapid Dose Announces Extension to Promissory Notes | 324 | Newsfile | Burlington, Ontario--(Newsfile Corp. - November 28, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that it intends to extend the maturity date of its outstanding... ► Artikel lesen | |
| 02:18 | Rakovina Therapeutics Inc: Rakovina Therapeutics Announces Debentureholder Approval of Debenture Extension, Expiry of Warrant Incentive Program | 132 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ("Rakovina" or the "Company") (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| AMGEN | 297,95 | 8,22 | +2,76 % | 2,38 | 21.11.2025 | |
| RECORDATI | 50,75 | 1,30 | +2,56 % | 0,63 | 24.11.2025 | |
| GENUS | 29,200 | 0,36 | +1,23 % | 0,22 | 06.11.2025 | |
| BIO-TECHNE | 57,50 | 0,27 | +0,47 % | 0,08 | 17.11.2025 | |
| REGENERON PHARMACEUTICALS | 670,20 | 3,04 | +0,45 % | 0,88 | 20.11.2025 | |
| CLINUVEL | 6,630 | 0,03 | +0,45 % | 0,05 | 04.09.2025 | |
| BRUKER | 41,990 | 0,17 | +0,40 % | 0,05 | 08.12.2025 | |
| BIOGEN | 157,30 | 0,00 | 0,00 % | |||
| ENZO BIOCHEM | 0,388 | 0,00 | 0,00 % | |||
| MYRIAD GENETICS | 6,650 | 0,00 | 0,00 % |